Antoni B. Chan

Reading, ENG, United Kingdom

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 33 publications

Maintained improvement in patient-reported outcomes in early axial spondyloarthritis following certolizumab pegol dose reduction: findings from the randomised period of a phase 3b trial.

Maintained improvement in patient-reported outcomes in early axial spondyloarthritis following certolizumab pegol dose reduction: findings from the randomised period of a phase 3b trial.

Journal: EULAR rheumatology open

Published: August 01, 2026

Five years of the Digital Rheumatology Network: insights and future directions.

Five years of the Digital Rheumatology Network: insights and future directions.

Journal: EULAR rheumatology open

Published: June 29, 2026

Rest is work and why switching off should not feel like guilt.

Rest is work and why switching off should not feel like guilt.

Journal: BMJ (Clinical research ed.)

Published: March 04, 2026

SpArking change for patients with psoriatic arthritis and axial spondyloarthritis in the UK: results from a UK Delphi consensus study.

SpArking change for patients with psoriatic arthritis and axial spondyloarthritis in the UK: results from a UK Delphi consensus study.

Journal: Rheumatology advances in practice

Published: September 26, 2025

Explainable machine learning for predicting disease flares in axial spondyloarthritis: A real-world electronic health record-based pilot study.

Explainable machine learning for predicting disease flares in axial spondyloarthritis: A real-world electronic health record-based pilot study.

Journal: Digital health

Published: August 26, 2025

Explainable machine learning-based prediction of psoriatic arthritis flares using heterogenous real-world data for personalised patient care.

Explainable machine learning-based prediction of psoriatic arthritis flares using heterogenous real-world data for personalised patient care.

Journal: Methods (San Diego, Calif.)

Published: August 13, 2025

Improved clinical care and capacity through an integrated electronic patient-reported outcome measure and health record system in inflammatory arthritis.

Improved clinical care and capacity through an integrated electronic patient-reported outcome measure and health record system in inflammatory arthritis.

Journal: Rheumatology advances in practice

Published: May 17, 2025

Executive Summary: The 2025 British Society for Rheumatology guideline for the treatment of axial spondyloarthritis with biologic and targeted synthetic DMARDs.

Executive Summary: The 2025 British Society for Rheumatology guideline for the treatment of axial spondyloarthritis with biologic and targeted synthetic DMARDs.

Journal: Rheumatology (Oxford, England)

Published: January 23, 2025

The 2025 British Society for Rheumatology guideline for the treatment of axial spondyloarthritis with biologic and targeted synthetic DMARDs.

The 2025 British Society for Rheumatology guideline for the treatment of axial spondyloarthritis with biologic and targeted synthetic DMARDs.

Journal: Rheumatology (Oxford, England)

Published: August 31, 2024

Progressive improvement in time to diagnosis in axial spondyloarthritis through an integrated referral and education system.

Progressive improvement in time to diagnosis in axial spondyloarthritis through an integrated referral and education system.

Journal: Rheumatology advances in practice

Published: June 23, 2024

Another Perspective of Over-Smoothing: Alleviating Semantic Over-Smoothing in Deep GNNs.

Another Perspective of Over-Smoothing: Alleviating Semantic Over-Smoothing in Deep GNNs.

Journal: IEEE transactions on neural networks and learning systems

Published: May 29, 2024

Improvement in spinal pain at night and its impact on long-term outcomes in radiographic axial spondyloarthritis: Results from Ixekizumab COAST-V randomised trial.

Improvement in spinal pain at night and its impact on long-term outcomes in radiographic axial spondyloarthritis: Results from Ixekizumab COAST-V randomised trial.

Journal: Seminars in arthritis and rheumatism

Published: April 12, 2024

Showing 1-12 of 33

Last Updated: 09/26/2026